Dr Pan Pantziarka is Programme Director Drug Repurposing of the Anticancer Fund and coordinator of the Repurposing Drugs in Oncology (ReDO) project. His areas of research include drug repurposing, bioinformatics, computational biology and genetic cancer predisposition. He has worked to develop clinical trials with clinicians in the UK and mainland Europe. He is also the co-founder and chair the George Pantziarka TP53 Trust – the UK’s only charity dedicated to supporting people with the rare genetic cancer condition called Li Fraumeni Syndrome.